Express Scripts Holding Profit Margin 2006-2018 | ESRX

Current and historical gross, operating and net profit margin for Express Scripts Holding (ESRX) over the last 10 years. The current net profit margin for Express Scripts Holding as of June 30, 2018 is 4.65%.
Express Scripts Holding Annual Profit Margin Summary
Express Scripts Holding Quarterly Profit Margin Summary
Sector Industry Market Cap Revenue
Medical Medical Services $49.133B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.770B 25.16
PRA Health Sciences (PRAH) United States $6.545B 28.56
Charles River Laboratories (CRL) United States $5.818B 21.25
HealthEquity (HQY) United States $5.401B 114.54
Teladoc (TDOC) United States $5.143B 0.00
Premier (PINC) United States $5.100B 20.63
INC Research Holdings (SYNH) United States $4.861B 21.58
NovoCure (NVCR) Jersey $3.293B 0.00
AMN Healthcare Services Inc (AMN) United States $2.717B 20.88
Medpace Holdings (MEDP) United States $2.057B 28.92
BioTelemetry (BEAT) United States $1.868B 42.82
Intrexon (XON) United States $1.857B 0.00
Natera (NTRA) United States $1.537B 0.00
Healthways (TVTY) United States $1.314B 18.56
IKang Healthcare (KANG) China $1.290B 71.42
China Cord Blood (CO) China $0.883B 23.61
Surgery Partners (SGRY) United States $0.846B 0.00
CareDx (CDNA) United States $0.628B 0.00
Apollo Medical Holdings (AMEH) United States $0.615B 0.00
Civitas Solutions (CIVI) United States $0.589B 11.61
Establishment Labs Holdings (ESTA) $0.541B 0.00
OncoCyte (OCX) United States $0.096B 0.00
Cancer Genetics (CGIX) United States $0.029B 0.00
Interpace Diagnostics (IDXG) United States $0.029B 0.00
OpGen (OPGN) United States $0.011B 0.00
Biocept (BIOC) United States $0.008B 0.00
FORM Holdings (XSPA) United States $0.004B 0.00